All News

2017

June

Media Release / Jun 12, 2017

Sandoz launches authorized generic version of Pataday® 0.2% ophthalmic solution

Read More

May

Media Release / May 08, 2017

Sandoz and DURECT to develop and market investigational non-opioid analgesic in the US

Read More

March

El Salvador Family
Featured News / Mar 23, 2017

The New Americares-Sandoz Partnership Provides Even More Access to Medicines

Sandoz announced a commitment of $10 million USD in medicines to Americares.

Read More
Media Release / Mar 06, 2017

New data demonstrate Sandoz proposed biosimilar adalimumab has equivalent efficacy to reference medicine

Read More

January

Media Release / Jan 04, 2017

Sandoz launches generic version of Emend® capsules

Read More
2016

December

Media Release / Dec 15, 2016

Sandoz acquires consumer skin care brand AmLactin®

Read More
Media Release / Dec 07, 2016

Sandoz launches generic version of Latisse®

Read More
Media Release / Dec 05, 2016

New interim data demonstrate Sandoz proposed biosimilar rituximab has equivalent efficacy to reference product

Read More

November

Media Release / Nov 22, 2016

Sandoz to donate up to USD 10 million of high-quality generic medicines annually to Americares to increase access to medicines

Read More

August

Media Release / Aug 31, 2016

AirFluSal® Forspiro® showed superiority at 12 months over Seretide® Diskus®[1] in persistence to treatment

Read More

Pages